[Federal Register Volume 79, Number 148 (Friday, August 1, 2014)]
[Notices]
[Pages 44866-44867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-18279]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Almac Clinical 
Services, Inc. (ACSI)

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Almac Clinical Services, Inc. (ACSI) applied to be registered 
as an importer of certain basic classes of narcotic controlled 
substances. The Drug Enforcement Administration (DEA) grants Almac 
Clinical Services, Inc. (ACSI) registration as an importer of those 
controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and 
published in the Federal Register on April 28, 2014, 79 FR 23373, Almac 
Clinical Services, Inc. (ACSI), 25 Fretz Road, Souderton, Pennsylvania 
18964, applied to be registered as an importer of certain basic classes 
of controlled substances. No comments or objections were submitted for 
this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Almac Clinical Services, Inc., (ACSI) to import the 
basic classes of controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of the basic classes of controlled 
substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------


[[Page 44867]]

    The company plans to import small quantities of the listed 
controlled substances in dosage form to conduct clinical trials.
    The import of the above listed basic classes of controlled 
substances is granted only for analytical testing and clinical trials. 
This authorization does not extend to the import of finished Food and 
Drug Administration approved or non-approved dosage forms for 
commercial distribution in the United States.

    Dated: July 22, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-18279 Filed 7-31-14; 8:45 am]
BILLING CODE 4410-09-P